All Articles

Positive Phase 3 data for BRUKINSA shows a 43% reduction in cancer progression, heralding a chemotherapy-free future for frontline mantle cell lymphoma.

The government's new National Food Security Strategy is more than a funding announcement; it's a systemic overhaul aiming to fix a fragile food system.

Facing a disconnect between its growing operations and its market price, Sucro Limited is reviewing its strategy. What does this move reveal about the future of sugar?

A landmark acquisition pairs a powerful AI engine with deep human expertise, signaling a new era for how brands connect with diverse audiences.

Private equity giant CD&R is deploying capital differently, investing $4.5M in five diverse NYC non-profits. It's a strategic play beyond simple charity.

A $50M Air Force contract for AEVEX isn't just another defense deal. It's a bet on tech that works without GPS, shaping a new US military strategy.

JCPenney is offering $10 for a gas receipt. A simple gimmick, or a shrewd strategic move to drive traffic and data in a brutal retail landscape?

Ouster's new BABA-compliant lidar sensors gain a critical edge, positioning the company to capture a major share of U.S. infrastructure spending.

With $135M from Salesforce and a vision from Chamath Palihapitiya, 8090 aims to revolutionize enterprise software with human-governed AI agents.

Promising 12-month trial data for SKY-0515 shows it may halt Huntington's, a first for an oral pill. This could disrupt the neuro-market.

For patients with inoperable brain tumors, new diagnostic guidelines offer hope by validating CSF profiling, a disruptive technology poised to redefine care.

Skyhawk Therapeutics' oral drug SKY-0515 not only stabilized but appeared to improve key metrics in Huntington's patients, a profound shift in a field long awaiting a breakthrough.

A new report reveals a massive gap between what shoppers expect and what stores deliver, costing retailers billions. Can AI-powered smart carts close the divide?

MEXC’s SpaceX products see $7.1B in trading, tapping huge retail demand. But as crypto bridges to Wall Street, is it building on solid ground or regulatory quicksand?

PowerBank secures $4.2M from new institutional investors, earmarking funds for critical U.S. federal projects and military energy independence.

xTool's new O1 Omni Printer combines four industrial printing methods into one desktop unit, aiming to revolutionize production for small businesses and creators.

OrangeX's shift to WOWX is more than a name change. It's a high-stakes gamble on compliance, hype, and a new trading philosophy. But will it work?

Kennametal's appointment of Amanda Cole as CHRO isn't just a leadership shuffle. It is a calculated response to the seismic shifts reshaping the industrial sector.

Kite Realty Group is executing a sophisticated financial maneuver, refinancing debt to cut costs while buying back shares—a dual strategy that signals confidence.

A new study reveals how Salipro Biotech's platform makes 'undruggable' membrane proteins accessible, a milestone that could reshape pharmaceutical R&D.